Entries by mercuric

‘Trialling tailored treatments for colorectal cancer’: A European Commission Research & Innovation Success Story

MErCuRIC was featured as a Horizon 2020 Success Story on the European Commission’s Policies, information and services webpage on April 14, 2018. Below is an excerpt from the story. “Made-to-measure treatments are becoming possible because of the growing understanding of the genetic and molecular nature of cancers and disease in general,” says Coordinator Sandra Van […]

MErCuRIC study published in Molecular Cancer Therapeutics

The MErCuRIC study ‘The unfolded protein response: a novel therapeutic target for poor prognostic BRAF mutant colorectal cancer’ has been recently published in Molecular Cancer Therapeutics. The body of research by Nicholas Forsythe, Alaa Refaat, Arman Javadi, Hajrah Khawaja, Jessica-Anne Weir, Heba Emam, Wendy L Allen, Frank Burkamp, Vlad Popovici, Puthen V Jithesh, Claudio Isella, Melissa J […]

MErCuRIC team from RECETOX, Masarykova Univerzita publish study results

‘A critical comparison of topology-based pathway analysis methods’ authored by the team of Dr Vlad Popovici at the Research Centre for Toxic Compounds in the Environment (RECETOX), Masarykova Univerzita has been recently published in PLoS One. The body of research by Ivana Ihnatova, Vlad Popovici and Eva Budinska appeared online on 25 January 2018. Abstract […]

NICTN | Celebrating a decade of advances in cancer research

The Northern Ireland Cancer Trials Network (NICTN) presented at an Open Day on 17 February 2018 hosted by the Centre for Cancer Research and Cell Biology (CCRCB) in Belfast, Northern Ireland, UK. As part of the NI Science Festival, the public was welcomed to the CCRCB Open Day on Saturday, 17 February 2018. The event ‘Celebrating […]

EuropaColon features a MErCuRIC patient’s perspective and our clinical trial

Through networking and information sharing, MErCuRIC is building bridges with colorectal cancer, personalised medicine and other stakeholder initiatives. Currently, MErCuRIC is featured on the EuropaColon website with our first patient perspective story written by Ed Goodall. Special thanks to Ed! To read the entire story, click here. In addition, please visit our new web page for patient […]

Reflections from EAPM 2017 where MErCuRIC PPI was Highlighted

The 1st European Alliance for Personalised Medicine (EAPM) Congress was held in Belfast in November 2017 where Margaret Grayson presented MErCuRIC’s mission and objectives with an emphasis of the Public and Patient Involvement (PPI) aspects of the project. Margaret, Chair, NI Cancer Research Consumer Forum commented, “The conference was a great opportunity for listening, talking, sharing and […]

EuropaColon Patients’ Survey on The Unmet Needs of Patients Living with Metastatic Colorectal Cancer

Bowel cancer/CRC patients: Please contribute to an important survey that will help EuropaColon understand how patients cope with a diagnosis of metastatic colorectal cancer. EuropaColon aims to unite patients, caregivers, healthcare professionals, politicians, the media and the public in the fight against digestive cancers. The Organisation works with 43 groups in 32 European countries and has […]

MErCuRIC team from the Università degli Studi di Torino publish in Nature

‘Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth’ by authors Giovanni Germano, Simona Lamba, Giuseppe Rospo, Ludovic Barault, Alessandro Magrì, Federica Maione, Mariangela Russo, Giovanni Crisafulli, Alice Bartolini, Giulia Lerda, Giulia Siravegna, Benedetta Mussolin, Roberta Frapolli, Monica Montone, Federica Morano, Filippo de Braud, Nabil Amirouchene-Angelozzi, Silvia Marsoni, Maurizio D’Incalci, Armando Orlandi, Enrico Giraudo, Andrea Sartore-Bianchi, Salvatore Siena, Filippo Pietrantonio, Federica Di Nicolantonio & Alberto Bardelli was published in Nature and online 29 November 2017.   Abstract: Molecular alterations […]

Two MErCuRIC publications from the Università degli Studi di Torino

Our MErCuRIC partners at the University of Torino (UNITO) have recently published two important papers. One appears in the October 5, 2017, edition of Gut, “Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer.” The second paper titled, “Tracking a CAD-ALK gene rearrangement in urine and blood […]